Extracellular matrix deposition in cultured dermal fibroblasts from four probands affected by osteogenesis imperfecta.

[1]  D. Prockop,et al.  Copolymerization of normal type I collagen with three mutated type I collagens containing substitutions of cysteine at different glycine positions in the alpha 1 (I) chain. , 1992, The Journal of biological chemistry.

[2]  P. Byers,et al.  Osteogenesis imperfecta: translation of mutation to phenotype. , 1991, Journal of medical genetics.

[3]  K. Kadler,et al.  A type I collagen with substitution of a cysteine for glycine-748 in the alpha 1(I) chain copolymerizes with normal type I collagen and can generate fractallike structures. , 1991, Biochemistry.

[4]  H. Kuivaniemi,et al.  Mutations in collagen genes: causes of rare and some common diseases in humans , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  P. Pignatti,et al.  A de novo G to T transversion in a pro-alpha 1 (I) collagen gene for a moderate case of osteogenesis imperfecta. Substitution of cysteine for glycine 178 in the triple helical domain. , 1991, The Journal of biological chemistry.

[6]  D. Prockop.  Mutations that alter the primary structure of type I collagen. The perils of a system for generating large structures by the principle of nucleated growth. , 1990, The Journal of biological chemistry.

[7]  R. Jaenisch,et al.  Transgenic mouse model of the mild dominant form of osteogenesis imperfecta. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W. Cole,et al.  Regulation of procollagen synthesis and processing during ascorbate-induced extracellular matrix accumulation in vitro. , 1990, The Biochemical journal.

[9]  S. Farmer,et al.  Regulation of alpha 1 (I)-collagen gene expression in response to cell adhesion in Swiss 3T3 fibroblasts. , 1990, The Journal of biological chemistry.

[10]  P. Pignatti,et al.  Segregation analysis of dominant osteogenesis imperfecta in Italy. , 1990, Journal of medical genetics.

[11]  P. Byers,et al.  Distinct biochemical phenotypes predict clinical severity in nonlethal variants of osteogenesis imperfecta. , 1990, American journal of human genetics.

[12]  J. Bateman,et al.  Assessment of procollagen processing defects by fibroblasts cultured in the presence of dextran sulphate. , 1990, The Biochemical journal.

[13]  P. Pignatti,et al.  Anomalous cysteine in type I collagen. Localisation by chemical cleavage of the protein using 2-nitro-5-thiocyanobenzoic acid and by mismatch analysis of cDNA heteroduplexes. , 1990, Matrix.

[14]  C. Mathew,et al.  Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2. , 1990, American journal of human genetics.

[15]  P. Byers,et al.  Frameshift mutation near the 3' end of the COL1A1 gene of type I collagen predicts an elongated Pro alpha 1(I) chain and results in osteogenesis imperfecta type I. , 1990, The Journal of clinical investigation.

[16]  P. Byers,et al.  Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. , 1989, The Journal of clinical investigation.

[17]  F. Grinnell,et al.  Collagen processing, crosslinking, and fibril bundle assembly in matrix produced by fibroblasts in long-term cultures supplemented with ascorbic acid. , 1989, Experimental cell research.

[18]  J. Engel,et al.  A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. , 1988, The Journal of biological chemistry.

[19]  D. Sillence.  Osteogenesis Imperfecta Nosology and Genetics , 1988, Annals of the New York Academy of Sciences.

[20]  J. Uitto,et al.  Collagen biosynthesis by human skin fibroblasts. I. Optimization of the culture conditions for synthesis of type I and type III procollagens. , 1980, Biochimica et biophysica acta.

[21]  H. Smilowitz,et al.  Monovalent ionophores inhibit secretion of procollagen and fibronectin from cultured human fibroblasts. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[22]  W. Bonner,et al.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. , 1974, European journal of biochemistry.